About kaken pharm - KKPCF
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operates through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.
KKPCF At a Glance
Kaken Pharmaceutical Co., Ltd.
2-28-8 Honkomagome
Tokyo, Tokyo 113-8650
| Phone | 81-3-5977-5001 | Revenue | 616.82M | |
| Industry | Pharmaceuticals: Major | Net Income | 91.47M | |
| Sector | Health Technology | 2025 Sales Growth | 23.643% | |
| Fiscal Year-end | 03 / 2026 | Employees | 1,126 | |
| View SEC Filings |
KKPCF Valuation
| P/E Current | 203.75 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 12.502 |
| Price to Sales Ratio | 1.854 |
| Price to Book Ratio | 1.127 |
| Price to Cash Flow Ratio | 5.85 |
| Enterprise Value to EBITDA | 4.528 |
| Enterprise Value to Sales | 1.136 |
| Total Debt to Enterprise Value | 0.037 |
KKPCF Efficiency
| Revenue/Employee | 547,800.803 |
| Income Per Employee | 81,236.584 |
| Receivables Turnover | 4.355 |
| Total Asset Turnover | 0.512 |
KKPCF Liquidity
| Current Ratio | 3.669 |
| Quick Ratio | 3.043 |
| Cash Ratio | 2.309 |
KKPCF Profitability
| Gross Margin | 61.958 |
| Operating Margin | 22.37 |
| Pretax Margin | 20.668 |
| Net Margin | 14.83 |
| Return on Assets | 7.599 |
| Return on Equity | 9.284 |
| Return on Total Capital | 8.741 |
| Return on Invested Capital | 9.284 |
KKPCF Capital Structure
| Total Debt to Total Equity | 2.522 |
| Total Debt to Total Capital | 2.46 |
| Total Debt to Total Assets | 2.022 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |